ACY-1083 is a selective and brain-penetrating HDAC6 inhibitor (IC50: 3 nM). It is 260-fold more selective for HDAC6 than all other classes of HDAC isoforms. ACY-1083 effectively reverses chemotherapy-induced peripheral neuropathy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 6-8 weeks | $ 212 | |
2 mg | 6-8 weeks | $ 381 | |
4 mg | 6-8 weeks | $ 540 | |
10 mg | 6-8 weeks | $ 1130 | |
20 mg | 6-8 weeks | $ 1762 |
Description | ACY-1083 is a selective and brain-penetrating HDAC6 inhibitor (IC50: 3 nM). It is 260-fold more selective for HDAC6 than all other classes of HDAC isoforms. ACY-1083 effectively reverses chemotherapy-induced peripheral neuropathy. |
Targets&IC50 | HDAC6:3 nM |
CAS No. | 1708113-43-2 |
Chemical Formula | C17H18F2N4O2 |
Molecular Weight | 348.354 |
Solubility | DMSO: 100 mg/mL (287.07 mM), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom